CPT1A and metabolic dysfunction-associated steatotic liver disease: A previous study demonstrated that CPT‐1 protein is decreased and that CPT‐1 protein oxidation, which might cause a decrease in the amount of active CPT‐1 protein, is promoted in an NAFLD model.34